CAMBRIDGE (CBS) — Moderna on Thursday announced it has filed for emergency use authorization of its COVID vaccine in adolescents 12 to 17 years old. This comes after a study showed its vaccine was 100% effective in teenagers.
“We are pleased to announce that we have submitted for an emergency use authorization for our COVID-19 vaccine with the FDA for use in adolescents in the United States,” said Moderna CEO Stéphane Bancel in a statement. “We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents.”READ MORE: Kim Janey Endorses Michelle Wu In Boston Mayoral Race
Not a single teen who received two doses of the vaccine came down with the coronavirus, the Cambridge-based biotech company said in late May. In addition, there were “no significant safety concerns identified,” and side effects were similar to those seen in adults.READ MORE: Gov. Baker Calls For Action Towards Ending Nurses' Strike At St. Vincent Hospital
Pfizer’s two-dose vaccine has already been authorized for use in everyone 12 years old and above. Both Moderna and Pfizer have begun testing the vaccines in children as young as 6 months old.
Children are less likely to get seriously ill from the coronavirus, but they are representing a higher percentage of cases as more adults get vaccinated.MORE NEWS: Lowell Family Closes On New Home Minutes Before Welcoming New Baby Girl
The Centers for Disease Control is urging parents to get their teens vaccinated as hospitalizations among young people increase.